Early evaluation of targeted therapy effectiveness in non-small cell lung cancer by dynamic contrast-enhanced CT. (Q52992671)

10 May 2018

title

Early evaluation of targeted therapy effectiveness in non-small cell lung cancer by dynamic contrast-enhanced CT. (English)

1 reference

10 May 2018

author name string

P-G Qiao

1

1 reference

10 May 2018

H-T Zhang

2

1 reference

10 May 2018

J Zhou

3

1 reference

10 May 2018

M Li

4

1 reference

10 May 2018

J-L Ma

5

1 reference

10 May 2018

N Tian

6

1 reference

10 May 2018

X-D Xing

7

1 reference

10 May 2018

G-J Li

8

1 reference

10 May 2018

publication date

5 August 2015

1 reference

10 May 2018

Clinical and Translational Oncology

published in

1 reference

10 May 2018

volume

18

1 reference

10 May 2018

issue

1

1 reference

10 May 2018

page(s)

47-57

1 reference

10 May 2018

cites work

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1007/S12094-015-1335-6

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-015-1335-6

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-015-1335-6

Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-015-1335-6

Targeting angiogenesis with multitargeted tyrosine kinase inhibitors in the treatment of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-015-1335-6

Evaluating variability in tumor measurements from same-day repeat CT scans of patients with non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-015-1335-6

Whole-tumor perfusion CT in patients with advanced lung adenocarcinoma treated with conventional and antiangiogenetic chemotherapy: initial experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-015-1335-6

Histologic Assessment of Non–Small Cell Lung Carcinoma after Neoadjuvant Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-015-1335-6

From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-015-1335-6

Lung cancer perfusion at multi-detector row CT: reproducibility of whole tumor quantitative measurements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-015-1335-6

Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-015-1335-6

Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-015-1335-6

Non-small cell lung cancer: detection of early response to chemotherapy by using contrast-enhanced dynamic and diffusion-weighted MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-015-1335-6

18F-FDG PET early response evaluation of locally advanced non-small cell lung cancer treated with concomitant chemoradiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-015-1335-6

Perfusion CT allows prediction of therapy response in non-small cell lung cancer treated with conventional and anti-angiogenic chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-015-1335-6

Body tumor CT perfusion protocols: optimization of acquisition scan parameters in a rat tumor model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-015-1335-6

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-015-1335-6

Relative Abundance of EGFR Mutations Predicts Benefit From Gefitinib Treatment for Advanced Non–Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-015-1335-6

Non-small cell lung cancer after surgery and chemoradiotherapy: follow-up and response assessment

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26243393

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Tumor response in patients with advanced non-small cell lung cancer: perfusion CT evaluation of chemotherapy and radiation therapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26243393

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12094-015-1335-6

1 reference

10 May 2018

1 reference

10 May 2018